Business Agreement for Bio R&D and Commercialization Collaboration

Domestic biotech company Ezcuris is establishing Jeongeup as its strategic base for new drug development. The city of Jeongeup announced on September 10 that Ezcuris Co., Ltd. and the Jeonbuk Advanced Bio Research Headquarters of the National Institute of Toxicological Research have signed a business agreement to cooperate on bio research and development as well as commercialization.

Ezcuris Establishes New Drug Development Hub in Jeongeup View original image

Under this agreement, both parties will collaborate on the following areas: ▲Research and development of new drug candidates ▲Preclinical research ▲Commercialization support ▲Utilization of and cooperation in research infrastructure. Ezcuris will use Jeongeup as a central R&D hub, while the city will support the company's establishment of research facilities and collaboration with local research institutes, focusing on the Jeonbuk R&D Special Zone.


Ezcuris is a biotech company specializing in developing new drugs utilizing protein-protein interactions (PPI). The company drew attention from the industry at the 'Bio International Convention 2026' held in San Diego, USA, this past June by announcing a joint research agreement with global pharmaceutical company AstraZeneca.


With a company conducting joint research with a global pharmaceutical giant establishing an R&D hub in Jeongeup, a new connection is expected to be formed within the local bio industry. This will enable local research institutions to contribute their infrastructure and expertise throughout the entire new drug development process—from R&D to preclinical studies and commercialization.


Jeongeup City sees the establishment of the Ezcuris hub as an opportunity to transform the foundation of the local bio industry.

Since April last year, the city has been promoting the 'Jeonbuk Advanced Bio Boost-Up Platform Project,' expanding the existing industry base from agro-life bio to the advanced bio sector. The key is to attract promising biotech companies to the region while building a system that connects companies and research institutions, supporting them at every stage from R&D to commercialization.



Lee Haksoo, Mayor of Jeongeup, stated, "We will create a bioindustry ecosystem in Jeongeup that connects to the world," and added, "By attracting excellent biotech companies and fostering collaboration between companies and research institutions, we will support the realization of new drug development and commercialization achievements in our region."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing